These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, New Mexico HPV Pap Registry Steering Committee. Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316 [Abstract] [Full Text] [Related]
23. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital. Tao X, Zhang H, Zhang H, Xiao J, Li J, Zhou X, Wang L, Zhao C. Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831 [Abstract] [Full Text] [Related]
24. Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results. Cohen D, Austin RM, Gilbert C, Freij R, Zhao C. Am J Clin Pathol; 2012 Oct; 138(4):517-23. PubMed ID: 23010706 [Abstract] [Full Text] [Related]
27. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM. Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480 [Abstract] [Full Text] [Related]
28. High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia. Rantshabeng PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, Sharma K, Masole CB, Moraka NO, Motsumi K, Maoto-Mokote AKT, Eshetu AB, Tawe L, Gaolathe T, Moyo S, Kyokunda LT. BMC Infect Dis; 2024 Oct 15; 24(1):1163. PubMed ID: 39407130 [Abstract] [Full Text] [Related]
29. Cervical Cancer Screening: A Review. Perkins RB, Wentzensen N, Guido RS, Schiffman M. JAMA; 2023 Aug 08; 330(6):547-558. PubMed ID: 37552298 [Abstract] [Full Text] [Related]
30. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany. Remschmidt C, Kaufmann AM, Hagemann I, Vartazarova E, Wichmann O, Deleré Y. Int J Gynecol Cancer; 2013 Mar 08; 23(3):519-26. PubMed ID: 23360813 [Abstract] [Full Text] [Related]
31. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Liman AK, Giampoli EJ, Bonfiglio TA. Cancer; 2005 Dec 25; 105(6):457-60. PubMed ID: 16104044 [Abstract] [Full Text] [Related]
35. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Dec 25; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]